Company Filing History:
Years Active: 1986-1996
Title: Kenji Takeda: Innovator in Cerebrovascular Disease Treatment
Introduction
Kenji Takeda is a prominent inventor based in Toyama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating cerebrovascular diseases. With a total of 6 patents to his name, Takeda's work has garnered attention in the scientific community.
Latest Patents
Among his latest patents are innovative compounds such as a 1,2-benzoisoxazole derivative or its salt, and a brain-protecting agent, specifically a piperazine derivative or its salt. These compounds are particularly noteworthy for their potential applications in curing cerebrovascular diseases and addressing post-cerebrovascular conditions. His research has led to the development of a piperazine derivative represented by a specific formula, which is useful in this medical field.
Career Highlights
Kenji Takeda has been associated with Toyama Chemical Co., Ltd., where he has played a crucial role in advancing pharmaceutical research. His dedication to innovation in drug development has positioned him as a key figure in the industry.
Collaborations
Takeda has collaborated with notable colleagues such as Hiroshi Sadaki and Hiroyuki Imaizumi, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Kenji Takeda's contributions to the field of cerebrovascular disease treatment through his patents and collaborations highlight his importance as an inventor. His work continues to pave the way for advancements in medical science.